In 2023, Singapore dominated the ranking of the world's health and health systems, followed by Japan and South Korea. The health index score is calculated by evaluating various indicators that assess the health of the population, and access to the services required to sustain good health, including health outcomes, health systems, sickness and risk factors, and mortality rates. The health and health system index score of the top ten countries with the best healthcare system in the world ranged between 82 and 86.9, measured on a scale of zero to 100.

Global Health Security Index  Numerous health and health system indexes have been developed to assess various attributes and aspects of a nation's healthcare system. One such measure is the Global Health Security (GHS) index. This index evaluates the ability of 195 nations to identify, assess, and mitigate biological hazards in addition to political and socioeconomic concerns, the quality of their healthcare systems, and their compliance with international finance and standards. In 2021, the United States was ranked at the top of the GHS index, but due to multiple reasons, the U.S. government failed to effectively manage the COVID-19 pandemic. The GHS Index evaluates capability and identifies preparation gaps; nevertheless, it cannot predict a nation's resource allocation in case of a public health emergency.

Universal Health Coverage Index  Another health index that is used globally by the members of the United Nations (UN) is the universal health care (UHC) service coverage index. The UHC index monitors the country's progress related to the sustainable developmental goal (SDG) number three. The UHC service coverage index tracks 14 indicators related to reproductive, maternal, newborn, and child health, infectious diseases, non-communicable diseases, service capacity, and access to care. The main target of universal health coverage is to ensure that no one is denied access to essential medical services due to financial hardships. In 2021, the UHC index scores ranged from as low as 21 to a high score of 91 across 194 countries. 

In 2023, Norway ranked first with a health index score of 83, followed by Iceland and Sweden. The health index score is calculated by evaluating various indicators that assess the health of the population, and access to the services required to sustain good health, including health outcomes, health systems, sickness and risk factors, and mortality rates. The statistic shows the health and health systems ranking of European countries in 2023, by their health index score.

Digital Eating Disorder Treatment Market Outlook

According to our latest research, the global digital eating disorder treatment market size reached USD 1.42 billion in 2024, reflecting the increasing adoption of digital health solutions in mental healthcare. The market is expected to expand at a robust CAGR of 14.8% during the forecast period, reaching an estimated USD 4.31 billion by 2033. This significant growth is driven by the rising prevalence of eating disorders worldwide, growing awareness about mental health, and the rapid integration of digital platforms into healthcare delivery models.

One of the primary growth factors for the digital eating disorder treatment market is the escalating incidence of eating disorders, such as anorexia nervosa, bulimia nervosa, and binge-eating disorder, particularly among adolescents and young adults. The World Health Organization has highlighted the growing burden of mental health disorders globally, with eating disorders ranking among the most fatal psychiatric conditions. The stigma surrounding traditional in-person therapy has led many individuals to seek more private, accessible, and stigma-free forms of care, which digital solutions are uniquely positioned to provide. Furthermore, the COVID-19 pandemic accelerated the shift toward remote healthcare, prompting both providers and patients to embrace telehealth, mobile apps, and web-based platforms for eating disorder management.

The integration of advanced technologies such as artificial intelligence, machine learning, and data analytics into digital eating disorder treatment platforms is another key driver of market expansion. These technologies enable personalized treatment plans, real-time monitoring, and predictive analytics, enhancing patient outcomes and engagement. Additionally, the proliferation of smartphones and internet connectivity has made digital health tools more accessible, even in remote or underserved regions. The ability of digital platforms to offer interactive modules, self-monitoring tools, and direct communication with healthcare professionals is revolutionizing the way eating disorders are treated, making care more continuous, responsive, and patient-centric.

Another significant factor propelling the growth of the digital eating disorder treatment market is the growing support from government agencies, healthcare organizations, and insurers for digital mental health interventions. Regulatory bodies in North America and Europe, in particular, have been proactive in updating guidelines to include digital therapies as part of standard care, thereby improving reimbursement frameworks and encouraging innovation. Partnerships between technology companies, academic institutions, and healthcare providers are also fostering the development of evidence-based digital interventions, further strengthening the market. The increased investment from venture capital and private equity firms in digital health startups focused on mental health and eating disorders is fueling the pace of innovation and market penetration.

Regionally, North America leads the global digital eating disorder treatment market, accounting for the largest revenue share in 2024. This dominance is attributed to the high prevalence of eating disorders, advanced healthcare infrastructure, and widespread acceptance of digital health solutions. Europe follows closely, driven by increasing mental health awareness, supportive regulatory policies, and robust healthcare systems. The Asia Pacific region is emerging as a high-growth market, propelled by rising internet penetration, growing mental health awareness, and expanding healthcare access. However, disparities in digital literacy and healthcare infrastructure in Latin America and the Middle East & Africa present both challenges and opportunities for market participants aiming to expand their footprint in these regions.

Component Analysis

The component segment of the digital eating disorder treatment market is bifurcated into software and s

Smart Peak-Flow Meter Market Outlook

According to our latest research, the global Smart Peak-Flow Meter market size reached USD 216.3 million in 2024, driven by the increasing prevalence of respiratory disorders and adoption of digital health technologies. The market is projected to expand at a robust CAGR of 9.8% from 2025 to 2033, reaching a forecasted value of USD 492.7 million by 2033. The primary growth factor propelling this market is the growing demand for advanced respiratory monitoring solutions, particularly for chronic conditions such as asthma and chronic obstructive pulmonary disease (COPD), combined with the rapid integration of smart technologies in healthcare.

The surge in respiratory diseases globally, especially asthma and COPD, is a significant catalyst for the Smart Peak-Flow Meter market. According to the World Health Organization, over 262 million people were affected by asthma in 2023, with COPD ranking as the third leading cause of death worldwide. This alarming prevalence has intensified the need for accurate, real-time monitoring tools, motivating both healthcare providers and patients to seek more reliable and user-friendly solutions. Smart peak-flow meters offer enhanced data accuracy, connectivity with digital platforms, and real-time alerts, enabling proactive disease management. The aging global population, particularly in developed regions, further amplifies demand as elderly individuals are more susceptible to respiratory ailments and require continuous monitoring for effective disease control.

Technological advancements represent another pivotal growth driver for the Smart Peak-Flow Meter market. The integration of Bluetooth, cloud connectivity, and advanced data analytics has revolutionized respiratory monitoring, making it more accessible and actionable. These features allow seamless data sharing between patients and healthcare professionals, fostering a more collaborative approach to disease management. Furthermore, the proliferation of telehealth services, especially post-pandemic, has accelerated the adoption of smart medical devices, with peak-flow meters playing a critical role in remote patient monitoring. The increasing penetration of smartphones and digital health apps also supports this trend, as users can effortlessly track and analyze their respiratory health over time, leading to better adherence to treatment regimens.

Healthcare policy reforms and rising awareness about preventive healthcare are also fueling market expansion. Governments and health organizations are actively promoting early diagnosis and continuous monitoring of chronic respiratory diseases to reduce hospitalization rates and healthcare costs. This has led to favorable reimbursement policies and funding for digital health innovations, creating a conducive environment for the growth of smart peak-flow meters. Additionally, collaborations between device manufacturers, healthcare providers, and technology firms are fostering the development of more sophisticated and cost-effective products, further accelerating market penetration across both developed and emerging economies.

Regionally, North America dominates the Smart Peak-Flow Meter market, accounting for the largest share in 2024 due to high healthcare expenditure, advanced healthcare infrastructure, and widespread adoption of digital health solutions. However, the Asia Pacific region is poised for the fastest growth, driven by increasing healthcare investments, rising awareness about respiratory health, and expanding access to smart medical devices in countries such as China, India, and Japan. Europe also holds a significant market share, supported by strong healthcare systems and ongoing initiatives to combat chronic respiratory diseases. Meanwhile, Latin America and the Middle East & Africa are gradually emerging as promising markets, propelled by improving healthcare infrastructure and rising disease burden, though challenges such as affordability and limited access persist in these regions.

Product Type Analysis

Among OECD member countries, the United States had the highest percentage of gross domestic product spent on health care as of 2023. The U.S. spent nearly ** percent of its GDP on health care services. Germany, France and Japan followed the U.S. with distinctly smaller percentages. The United States had both significantly higher private and public spending on health compared with other developed countries. Why compare OECD countries?OECD stands for Organization for Economic Co-operation and Development. It is an economic organization consisting of ** members, mostly high-income countries and committed to democratic principles and market economy. This makes OECD statistics more comparable than statistics of developed and undeveloped countries. Health economics is an important matter for the OECD, even more since increasing health costs and an aging population have become an issue for many developed countries. Health costs in the U.S.  A higher GDP share spent on health care does not automatically lead to a better functioning health system. In the case of the U.S., high spending is mainly because of higher costs and prices, not due to higher utilization. For example, physicians’ salaries are much higher in the U.S. than in other comparable countries. A doctor in the U.S. earns almost twice as much as the average physician in Germany. Pharmaceutical spending per capita is also distinctly higher in the United States. Furthermore, the U.S. also spends more on health administrative costs compare to other wealthy countries.

Healthcare spending in the United Kingdom (UK) as a share of the gross domestic product (GDP) has increased since 1990, when it was 5.1 percent. By 2023, healthcare expenditure in the UK amounted 10.9 percent of the GDP. Health expenditure in the UK compared to Europe  In comparison to other European countries in 2022, the UK ranked fifth highest in terms of healthcare spending as a share of the GDP. Top of the list was Germany, which spent 12.7 percent of its GDP on healthcare in this year. This was followed by France and Austria, which spent 11.9 percent and 11.4 percent on health, respectively. Performance of the NHS in the UK  Individuals in the UK still regard the NHS as a world class health service and remain happy with the high level of care provided by the organization. Although waiting times have been getting worse in the A&E department over the years. The NHS has been falling behind the target that 95 percent of patients should be seen within four hours of arrival. As a result, the primary reasons for dissatisfaction with the NHS among the public are the length of time required to get a GP or hospital appointment and the lack of staff.